KYOWA KIRIN CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,612 JPY | -1.56% |
|
-2.14% | +10.23% |
| May. 07 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
| May. 06 | Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 474B 3.04B | Sales 2025 * | 485B 3.12B | Capitalization | 1,392B 8.94B |
|---|---|---|---|---|---|
| Net income 2024 * | 66.8B 429M | Net income 2025 * | 72.63B 466M | EV / Sales 2024 * | 2.25 x |
| Net cash position 2024 * | 328B 2.1B | Net cash position 2025 * | 360B 2.31B | EV / Sales 2025 * | 2.13 x |
| P/E ratio 2024 * |
20.7
x | P/E ratio 2025 * |
19.1
x | Employees | 5,974 |
| Yield 2024 * |
2.24% | Yield 2025 * |
2.33% | Free-Float | 45.89% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -1.56% | ||
| 1 week | -2.14% | ||
| Current month | -1.38% | ||
| 1 month | -0.85% | ||
| 3 months | -9.51% | ||
| 6 months | +7.05% | ||
| Current year | +10.23% |
1 week
2 593.00
2 716.00
1 month
2 593.002 716.00
Current year
2 266.503 009.00
1 year
2 266.503 009.00
3 years
2 266.504 240.00
5 years
1 674.004 240.00
10 years
1 094.004 240.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 86-03-31 | |
Masashi Miyamoto
PSD | President | 64 | 85-03-31 |
| Chief Tech/Sci/R&D Officer | 62 | 10-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Takashi Oyamada
BRD | Director/Board Member | 68 | 21-02-28 |
Yoshihisa Suzuki
BRD | Director/Board Member | 68 | 22-02-28 |
| Director/Board Member | 66 | 08-09-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.22% | 19 M€ | +11.32% | ||
| 0.44% | 10 M€ | +16.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 2,612 | -1.56% | 987,300 |
| 24-05-16 | 2,654 | +0.57% | 972,100 |
| 24-05-15 | 2,639 | -2.06% | 1,136,000 |
| 24-05-14 | 2,694 | +0.86% | 962,400 |
| 24-05-13 | 2,672 | +0.07% | 762,800 |
Delayed Quote Japan Exchange, May 17, 2024 at 02:00 am EDT
More quotes
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,612
JPY
Average target price
3,054
JPY
Spread / Average Target
+16.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.23% | 8.96B | |
| +16.03% | 79.03B | |
| -10.76% | 5.19B | |
| +51.58% | 4.77B | |
| +12.50% | 4.26B | |
| -20.70% | 2.37B | |
| +12.83% | 2.3B | |
| -29.65% | 2.21B | |
| +19.51% | 2.17B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 4151 Stock
